An Open-Label Exploratory Study with Memantine: Correlation between Proton Magnetic Resonance Spectroscopy and Cognition in Patients with Mild to Moderate Alzheimer's Disease

被引:0
|
作者
Gordon, Marc [1 ]
Kingsley, Peter [2 ]
Goldberg, Terry
Koppel, Jeremy
Christen, Erica
Keehlisen, Lynda
Kohn, Nina [3 ]
Davies, Peter
机构
[1] N Shore LIJ Hlth Syst, Litwin Zucker Res Ctr, Neurol & Psychiat, Manhasset, NY USA
[2] N Shore LIJ Hlth Syst, Radiol, Manhasset, NY USA
[3] N Shore LIJ Hlth Syst, Biostat, Manhasset, NY USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P04198
引用
收藏
页数:3
相关论文
共 50 条
  • [31] Proton Magnetic Resonance Spectroscopy in Alzheimer's disease, a review
    Loos, Caroline
    Achten, Eric
    Santens, Patrick
    ACTA NEUROLOGICA BELGICA, 2010, 110 (04) : 291 - 298
  • [32] Brain proton magnetic resonance spectroscopy in Alzheimer's disease
    Xie, HG
    Cheng, LQ
    Wang, LM
    Cai, YQ
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S482 - S482
  • [33] A 25-week, open-label trial investigating rivastigmine transdermal patches with concomitant memantine in mild-to-moderate Alzheimer's disease: a post hoc analysis
    Farlow, Martin R.
    Alva, Gus
    Meng, Xiangyi
    Olin, Jason T.
    CURRENT MEDICAL RESEARCH AND OPINION, 2010, 26 (02) : 263 - 269
  • [34] Sustained Effects of Once-Daily Memantine Treatment on Cognition and Functional Communication Skills in Patients with Moderate to Severe Alzheimer's Disease: Results of a 16-Week Open-Label Trial
    Schulz, Joerg B.
    Rainer, Michael
    Kluenemann, Hans-Hermann
    Kurz, Alexander
    Wolf, Stefanie
    Sternberg, Kati
    Tennigkeit, Frank
    JOURNAL OF ALZHEIMERS DISEASE, 2011, 25 (03) : 463 - 475
  • [35] Open-Label, Multicenter, Phase III Extension Study of Idalopirdine as Adjunctive to Donepezil for the Treatment of Mild-Moderate Alzheimer's Disease
    Froelich, Lutz
    Atri, Alireza
    Ballard, Clive
    Tariot, Pierre N.
    Luis Molinuevo, Jose
    Boneva, Neli
    Geist, Marie A.
    Raket, Lars L.
    Cummings, Jeffrey L.
    JOURNAL OF ALZHEIMERS DISEASE, 2019, 67 (01) : 303 - 313
  • [36] An Open-Label, Exploratory Study of the Efficacy and Safety of Repetitive Transcranial Magnetic Coil Stimulation (rTMS) in Aphasia in Alzheimer's Disease
    Devi, Gayatri
    Shin, Elizabeth
    Heier, Linda
    Voss, Henning
    Halper, James
    Lowe, Sandlin
    Lo, Vanessa
    NEUROLOGY, 2010, 74 (09) : A480 - A480
  • [37] Risankizumab in patients with moderate to severe Crohn's disease: an open-label extension study
    Feagan, Brian G.
    Panes, Julian
    Ferrante, Marc
    Kaser, Arthur
    D'Haens, Geert R.
    Sandborn, William J.
    Louis, Edouard
    Neurath, Markus F.
    Franchimont, Denis
    Dewit, Olivier
    Seidler, Ursula
    Kim, Kyung-Jo
    Selinger, Christian
    Padula, Steven J.
    Herichova, Ivona
    Robinson, Anne M.
    Wallace, Kori
    Zhao, Jun
    Minocha, Mukul
    Othman, Ahmed A.
    Soaita, Adina
    Visvanathan, Sudha
    Hall, David B.
    Boecher, Wulf O.
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2018, 3 (10): : 671 - 680
  • [38] Correlation between abnormal cellular immune and changes of magnetic resonance spectroscopy in patients with Alzheimer's disease
    Zeng, Hongmei
    Zhang, Qifang
    Liu, Lijie
    Deng, Feifei
    Han, Huabo
    Meng, Fuxue
    Bai, Hua
    NEUROCHEMISTRY INTERNATIONAL, 2024, 176
  • [39] Long-Term Follow Up of Patients with Mild-to-Moderate Alzheimer's Disease Treated with Bapineuzumab in a Phase III, Open-Label, Extension Study
    Salloway, Stephen P.
    Sperling, Reisa
    Fox, Nick C.
    Sabbagh, Marwan N.
    Honig, Lawrence S.
    Porsteinsson, Anton P.
    Rofael, Hany
    Ketter, Nzeera
    Wang, Daniel
    Liu, Enchi
    Carr, Stephen
    Black, Ronald S.
    Brashear, H. Robert
    JOURNAL OF ALZHEIMERS DISEASE, 2018, 64 (03) : 689 - 707
  • [40] Correlation of neuropsychological findings in patients with mild to moderate Alzheimer's disease
    Pavlovic, D. M.
    Pavlovic, A. M.
    Pekmezovic, T.
    EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 : 40 - 41